The outlook of companies tied to iconic drugs like Viagra presents a challenging investment landscape . While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the expiry in key territories has introduced significant volatility. Investors are now assessing the impact of generic competition ,